BMC Cardiovascular Disorders · 2016 · 34 citations · 22 references
MedicineCardiologySurgeryClinical CardiologyInterventional CardiologyUltrasonographyBalloon AngioplastyCoronary AngioplastyCoronary Artery DiseaseIntravascular ImagingPercutaneous Coronary InterventionStent PlacementCalcified Coronary Lesion TreatmentCalcified Lesion ModificationClinical Outcomes After Percutaneous Coronary InterventionCoronary CalcificationCoronary Plaque ModificationPercutaneous Coronary Intervention CarePrimary Outcome AnalysisSeverely Calcified Coronary Lesions
BACKGROUND: This study investigated whether, for patients with severely calcified coronary lesions, use of a cutting balloon (CB) during rotational atherectomy (RA) before placing a drug-eluting stent will improve periprocedural outcomes, compared to RA with a conventional plain balloon. METHODS: In a randomized controlled trial, patients with severely calcified lesions of calcium arc ≥180° were apportioned to receive intensive plaque modification with RA and CB (RA + CB; n = 35) or RA with conventional plain balloon (RA; n = 36). Intravascular ultrasound was applied for quantitative or qualitative analyses of percutaneous coronary intervention outcomes. The primary outcome was acute lumen gain after drug-eluting stent. RESULTS: The RA + CB and RA groups were similar in baseline mean arcs of superficial calcium, and minimum lumen cross-sectional areas (CSAs). The mean minimum stent CSA after percutaneous coronary intervention (PCI) of the RA + CB group (5.9 ± 1.7 mm(2)) was significantly larger than that of the RA group (5.0 ± 1.4 mm(2); P = 0.021). Patients in the RA + CB group achieved significantly larger acute CSA gain after PCI (4.5 ± 1.5 mm(2)) relative to the RA group (3.8 ± 1.5 mm(2); P = 0.035). The groups were similar in rates of periprocedural complications, but at the 1-year follow-up the RA + CB had a lower rate of revascularization for restenosis of the target vessel and MACE (5.7 %) than did the RA group (22.2 %, P = 0.046). CONCLUSION: Aggressive plaque preparation with RA and CB seems to be safe and effective for patients with severely calcified coronary lesions. TRIAL REGISTRATION: Current Controlled Trials ChiCTR-INR-16008274 . Retrospectively registered 12 April 2016.
22
2014 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2014 · 4.3K citations · Full text
Medicine, Cardiology, Surgery +14
2014 ESC/EACTS Guidelines on myocardial revascularization
Philippe Kolh, Stephan Windecker, Fernándo Alfonso et al. · European Journal of Cardio-Thoracic Surgery · 2014 · 4.2K citations · Full text
Medicine, Cardiology, Surgery +14
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Circulation · 2011 · 3.3K citations · Full text
Medicine, Cardiology, Surgery +14
Third Universal Definition of Myocardial Infarction
Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe et al. · Journal of the American College of Cardiology · 2012 · 2.6K citations
Third universal definition of myocardial infarction
Nature Reviews Cardiology · 2012 · 2.1K citations